Placebo, Obicetrapib 10 mg + ezetimibe 10 mg fixed dose combination (FDC)
OBEZ-302
Phase 3 small_molecule active
Quick answer
Placebo, Obicetrapib 10 mg + ezetimibe 10 mg fixed dose combination (FDC) for Atherosclerotic Cardiovascular Disease is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- Atherosclerotic Cardiovascular Disease
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active